Royal Society of Chemistry, RSC Advances, 47(13), p. 33080-33095, 2023
DOI: 10.1039/d3ra06189b
Full text: Download
We reported a novel 2-coumarin-substituted-quinoxaline analogue (3b) with potential antiproliferative activity against MCF-7 breast cancer cells by inducing cell cycle arrest and targeting topoisomerase II, and EGFR activity.